Volume | 113,127 |
|
|||||
News | - | ||||||
Day High | 3.216 | Low High |
|||||
Day Low | 3.11 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Ovid Therapeutics Inc | OVID | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.18 | 3.11 | 3.216 | 3.15 | 3.20 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,384 | 113,127 | $ 3.15 | $ 356,139 | - | 2.57 - 4.1389 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:20:00 | 6 | $ 3.15 | USD |
Ovid Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
223.44M | 70.71M | - | 392k | -52.34M | -0.74 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ovid Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OVID Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.18 | 3.29 | 3.05 | 3.18 | 176,111 | -0.03 | -0.94% |
1 Month | 3.05 | 3.35 | 3.00 | 3.15 | 142,631 | 0.10 | 3.28% |
3 Months | 3.91 | 4.10 | 2.60 | 3.18 | 214,697 | -0.76 | -19.44% |
6 Months | 3.56 | 4.10 | 2.57 | 3.25 | 173,242 | -0.41 | -11.52% |
1 Year | 3.17 | 4.1389 | 2.57 | 3.47 | 199,969 | -0.02 | -0.63% |
3 Years | 3.67 | 4.80 | 1.405 | 3.37 | 224,600 | -0.52 | -14.17% |
5 Years | 1.98 | 10.45 | 1.405 | 3.97 | 653,726 | 1.17 | 59.09% |
Ovid Therapeutics Description
Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life. |